Doris Day, MD, is putting the phrase anti-aging itself under the microscope. Her new feature in Dermatology Times runs under the headline "Doris Day, MD, on Redefining Anti-Aging in Dermatology," and the title signals the argument before readers reach the byline.

The piece lands as the aesthetic side of dermatology faces a vocabulary problem. Patients walk in asking to look younger. Clinicians increasingly talk about looking healthier. The gap between those two framings is what Day is pressing on.

What the headline tells readers

Day is a board-certified dermatologist with a long public footprint on aesthetic medicine. A Dermatology Times byline gives her reframe a clinical audience rather than a consumer one. That matters. The readership here is not deciding which serum to buy. It is deciding how to run a consult.

The available material is the headline and the framing "redefining anti-aging." That phrasing does work. It positions the conversation away from chronology and toward skin function: barrier integrity, photodamage, collagen quality, microbiome.

What does this change for the consult room?

Practitioners will recognize the tension. A patient asks for a filler. The clinical answer may be a retinoid, a device pass, or a sunscreen audit first. That sequencing is the operational test of any "redefinition."

Three practical pressure points show up:

• Intake language that asks about skin behavior, not just lines
• Treatment plans ordered by skin health goals, with injectables sequenced in later
• Follow-up cadence measured in months, not the standard two-week check

If Day's argument holds in print, expect those adjustments to get a wider clinical airing. Whether the broader aesthetic community picks up the reframe is the open question.

What to watch

The terminology fight runs straight into marketing. Practices still sell "anti-aging" services because patients still search the term. Day's piece is unlikely to retire the phrase on its own. It does give dermatologists cover to use a different one in the room.

Full coverage of the feature, including Day's specific clinical points, will surface in Dermatology Times' forthcoming issue. Watch that issue for the practical specifics the headline only hints at.